SIEMENS MEDICAL SOLUTIONS USA, INC

15 federal lobbying filings, 2023 to 2026.

SIEMENS MEDICAL SOLUTIONS USA, INC is a registrant on 15 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Clients

1 who it filed for, by filings.

Client	Filings	Reported
SIEMENS MEDICAL SOLUTIONS USA, INC	15	—

By year

Filings and what they reported, newest year first.

Year	Filings	Income	Expenses
2026	2	—	$1.6M
2025	5	—	$3.6M
2024	4	—	$2.8M
2023	4	—	$1.5M

Issues

The LDA issue codes the filings were filed under.

Code	Issue	Filings
`HCR`	Health Issues	15
`MMM`	Medicare/Medicaid	14
`BUD`	Budget/Appropriations	12
`TRD`	Trade (domestic/foreign)	11
`MED`	Medical/Disease Research/Clinical Labs	9
`DEF`	Defense	7
`TAR`	Tariff (miscellaneous tariff bills)	7
`EDU`	Education	5
`ENG`	Energy/Nuclear	4
`LBR`	Labor Issues/Antitrust/Workplace	4
`NAT`	Natural Resources	3
`TAX`	Taxation/Internal Revenue Code	3
`VET`	Veterans	3
`SCI`	Science/Technology	1

Bills

The bills the filings name, by how many name them.

Bill	Title	Filings
S. 1399	Health Tech Investment Act	7
S. 1717	Ensuring Patient Access to Critical Breakthrough Products Act of 2025	6
H.R. 3838	Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…	4
H.R. 4121	Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026	4
H.R. 4417	Mobile Cancer Screening Act	4
H.R. 5269	RESULTS Act	4
S. 2761	RESULTS Act	4
S. 2927	Mobile Cancer Screening Act	4
H.R. 1	An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.	3
H.R. 5304	Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026	3
H.R. 5343	Ensuring Patient Access to Critical Breakthrough Products Act	3
H.R. 6197	Health Tech Investment Act	3
H.R. 1406	Lung Cancer Screening and Prevention Act of 2025	2
H.R. 2120	ROCR Value Based Program Act	2
H.R. 2319	Women and Lung Cancer Research and Preventive Services Act of 2025	2
H.R. 2477	Portable Ultrasound Reimbursement Equity Act of 2025	2
H.R. 5371	Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…	2
S. 1031	ROCR Value Based Program Act	2
S. 1157	Women and Lung Cancer Research and Preventive Services Act of 2025	2
S. 1168	Portable Ultrasound Reimbursement Equity Act of 2025	2
S. 2256	Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026	2
S. 2882	Continuing Appropriations and Extensions and Other Matters Act, 2026	2
H.R. 1968	Full-Year Continuing Appropriations and Extensions Act, 2025	1
H.R. 2381	SCREENS for Cancer Act of 2025	1
H.R. 2385	CREATE AI Act of 2025	1

Lobbyists

Named on the filings.

Lobbyist	Clients	Filings
CATHERINE NABAVI	1	15
AARON HUNTER	1	13
JENNIFER KUSKOWSKI	1	12
NICOLE ZUK	1	8
SARAH GIANNI	1	7
ELEANOR KERR	1	4
ELIZABETH KEGLER	1	4
VALERIE SINDEN	1	4

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

Lobbying Finance